94 related articles for article (PubMed ID: 3054004)
1. How expert physicians would wish to be treated if they had genitourinary cancer.
Moore MJ; O'Sullivan B; Tannock IF
J Clin Oncol; 1988 Nov; 6(11):1736-45. PubMed ID: 3054004
[TBL] [Abstract][Full Text] [Related]
2. Are treatment strategies of urologic oncologists influenced by the opinions of their colleagues?
Moore MJ; O'Sullivan B; Tannock IF
Br J Cancer; 1990 Dec; 62(6):988-91. PubMed ID: 2257231
[TBL] [Abstract][Full Text] [Related]
3. Controversies in the management of non-small cell lung cancer: the results of an expert surrogate study.
Palmer MJ; O'Sullivan B; Steele R; Mackillop WJ
Radiother Oncol; 1990 Sep; 19(1):17-28. PubMed ID: 2173043
[TBL] [Abstract][Full Text] [Related]
4. How American oncologists treat breast cancer: an assessment of the influence of clinical trials.
Belanger D; Moore M; Tannock I
J Clin Oncol; 1991 Jan; 9(1):7-16. PubMed ID: 1985172
[TBL] [Abstract][Full Text] [Related]
5. [The origin of informed consent].
Mallardi V
Acta Otorhinolaryngol Ital; 2005 Oct; 25(5):312-27. PubMed ID: 16602332
[TBL] [Abstract][Full Text] [Related]
6. A population-based study of the prevalence and influence of gifts to radiation oncologists from pharmaceutical companies and medical equipment manufacturers.
Halperin EC; Hutchison P; Barrier RC
Int J Radiat Oncol Biol Phys; 2004 Aug; 59(5):1477-83. PubMed ID: 15275735
[TBL] [Abstract][Full Text] [Related]
7. Views of American oncologists about the purposes of clinical trials.
Joffe S; Weeks JC
J Natl Cancer Inst; 2002 Dec; 94(24):1847-53. PubMed ID: 12488478
[TBL] [Abstract][Full Text] [Related]
8. Residents' experiences in, and attitudes toward, the care of persons with AIDS in Canada, France, and the United States.
Shapiro MF; Hayward RA; Guillemot D; Jayle D
JAMA; 1992 Jul 22-29; 268(4):510-5. PubMed ID: 1619743
[TBL] [Abstract][Full Text] [Related]
9. Physician attitudes toward cytotoxic chemotherapy use in patients with advanced prostate carcinoma.
Oh WK; Tully P; Kantoff PW; Regan MM
Cancer; 2003 May; 97(9):2171-9. PubMed ID: 12712468
[TBL] [Abstract][Full Text] [Related]
10. The use of expert surrogates to evaluate clinical trials in non-small cell lung cancer.
Mackillop WJ; Ward GK; O'Sullivan B
Br J Cancer; 1986 Oct; 54(4):661-7. PubMed ID: 3022780
[TBL] [Abstract][Full Text] [Related]
11. Doctor-patient communication about breast cancer adjuvant therapy.
Siminoff LA; Fetting JH; Abeloff MD
J Clin Oncol; 1989 Sep; 7(9):1192-200. PubMed ID: 2671280
[TBL] [Abstract][Full Text] [Related]
12. Clinical trial discussion, referral, and recruitment: physician, patient, and system factors.
Kaplan CP; Nápoles AM; Dohan D; Shelley Hwang E; Melisko M; Nickleach D; Quinn JA; Haas J
Cancer Causes Control; 2013 May; 24(5):979-88. PubMed ID: 23420328
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant chemotherapy for breast cancer: discordance between physicians' perception of benefit and the results of clinical trials.
Rajagopal S; Goodman PJ; Tannock IF
J Clin Oncol; 1994 Jun; 12(6):1296-304. PubMed ID: 8201392
[TBL] [Abstract][Full Text] [Related]
14. Differences of opinion: a survey of knowledge and bias among clinicians regarding the role of chemotherapy in metastatic non-small cell lung cancer.
Jennens RR; de Boer R; Irving L; Ball DL; Rosenthal MA
Chest; 2004 Dec; 126(6):1985-93. PubMed ID: 15596703
[TBL] [Abstract][Full Text] [Related]
15. Differences between urologists in United States and Canada in approach to bladder cancer.
Chung D; Hersey K; Fleshner N
Urology; 2005 May; 65(5):919-25. PubMed ID: 15882724
[TBL] [Abstract][Full Text] [Related]
16. [The analysis of physicians' work: announcing the end of attempts at in vitro fertilization].
Santiago-Delefosse M; Cahen F; Coeffin-Driol C
Encephale; 2003; 29(4 Pt 1):293-305. PubMed ID: 14615699
[TBL] [Abstract][Full Text] [Related]
17. Clinical implementation of quality of life instruments and prediction tools for localized prostate cancer: results from a national survey of radiation oncologists and urologists.
Kim SP; Karnes RJ; Nguyen PL; Ziegenfuss JY; Han LC; Thompson RH; Trinh QD; Sun M; Boorjian SA; Beebe TJ; Tilburt JC
J Urol; 2013 Jun; 189(6):2092-8. PubMed ID: 23219546
[TBL] [Abstract][Full Text] [Related]
18. Clinical trials in cancer: the role of surrogate patients in defining what constitutes an ethically acceptable clinical experiment.
Mackillop WJ; Palmer MJ; O'Sullivan B; Ward GK; Steele R; Dotsikas G
Br J Cancer; 1989 Mar; 59(3):388-95. PubMed ID: 2930704
[TBL] [Abstract][Full Text] [Related]
19. Specialty bias in treatment recommendations and quality of life among radiation oncologists and urologists for localized prostate cancer.
Kim SP; Gross CP; Nguyen PL; Smaldone MC; Thompson RH; Shah ND; Kutikov A; Han LC; Karnes RJ; Ziegenfuss JY; Tilburt JC
Prostate Cancer Prostatic Dis; 2014 Jun; 17(2):163-9. PubMed ID: 24566445
[TBL] [Abstract][Full Text] [Related]
20. Prostate-specific antigen testing in Ontario: reasons for testing patients without diagnosed prostate cancer.
Bunting PS; Goel V; Williams JI; Iscoe NA
CMAJ; 1999 Jan; 160(1):70-5. PubMed ID: 9934349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
